by Nathi Magubane, University of Pennsylvania Credit: Pixabay/CC0 Public Domain In a significant step forward in neurotechnology, companies that make implantable brain-computer interfacing (BCI) devices, such as Neuralink, have received approval from the U.S. Food and Drug Administration (FDA) to conduct human clinical studies. BCIs have been around for a few decades; however, many companies and institutes have...
